Latest Lipodystrophy Stories

2014-05-29 04:21:56

AHMEDABAD, India, May 29, 2014 /PRNewswire/ -- Commences Phase III trials of Lipaglyn(TM) (Saroglitazar) in patients suffering from Lipodystrophy Exploring

2014-03-04 23:31:31

Patients, Researchers, Industry and Leading Medical Experts Join Forces to Gain Patient Population Information San Mateo, CA (PRWEB) March 04, 2014 PatientCrossroads,

2011-06-04 10:45:00

SAN DIEGO, June 4, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc.

2010-12-20 07:00:00

SAN DIEGO, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S.

2010-11-11 06:35:00

ROCKLAND, Mass., Nov. 11, 2010 /PRNewswire/ -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the U.S.

2010-11-10 18:00:00

SILVER SPRING, Md., Nov. 10 /PRNewswire-USNewswire/ -- The U.S.

2008-11-06 15:00:28

Theratechnologies (TSX: TH) announced today that new 26-week data from a combined analysis of both its Phase 3 clinical trials testing tesamorelin in HIV-associated lipodystrophy were presented as a poster (Poster Number 19) at the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, in London, England.

2008-08-04 12:01:30

Theratechnologies (TSX: TH) today announced positive data related to body image for patients treated with tesamorelin in both its first and confirmatory Phase 3 clinical trials, in two poster presentations at the XVII International AIDS Conference in Mexico City, Mexico.

Word of the Day
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.